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Abstract: Gelatin’s excellent foaming ability allows the application of in-situ gas 
foaming as a preparation technique for porous scaffold development. Here, a new iterative 
experimental design for in-situ gas foaming method is reported. The prepared scaffolds were 
studied for applying the findings to the future skin tissue engineering scaffolds. The thermal 
stability, mechanical properties, and pore structure of the scaffolds are reported and their 
degradation resistance by using collagenase enzyme and their cytotoxicity by using 
fibroblasts were studied. The results of this study demonstrated that gas foaming method can 
be modified to produce an interconnected porous structure with enhanced mechanical 
properties. 
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1. Introduction 
Porosity plays an important role in ensuring the optimum functioning of tissue 
engineering scaffolds by accelerating metabolite transport and facilitating cell migration and 
proliferation [1]. This has prompted researchers to constantly envisage more effective 
methods for obtaining porous scaffolds with better characteristics. Gas foaming is a technique 
used to prepare scaffolds with a desirable porosity [2]. The term Gas foaming may refer to 
the method of infusing a confined polymeric precursor in liquid state with pressurised gas [3]. 
However, this method requires expensive hardware and significant investment costs. In order 
to turn it into a more affordable and accessible technique, gas foaming may be performed in 
conjunction with an in-situ chemical reaction that transforms the liquid precursor into foam 
and eventually a solid porous structure [4]. The method comprises of a liquid phase, gasified 
through a thermal decomposition or chemical reaction [5]. Different materials show different 
abilities to form a stable foam. Materials with suitable surfactant properties usually have a 
desirable foaming ability. Gelatin is well known to possess such ability and hence is a 
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suitable candidate for being processed via a gas foaming technique [6]. We previously 
reported the development of a novel variation of in-situ gas foaming [7]; however, we 
observed that a high rate of CO2 release led to an undesirable low tensile strength of the 
samples. Therefore the focus of current report explores further optimisation of the process 
central parameters, with a specific attention to the sequence of gas release. 
In the last two decades skin tissue engineering scaffolds have been widely used in 
commercially-available wound dressings to improve the rate of healing in chronic wounds 
[8]. Since collagen is the main protein constituent of skin, a significant portion of the 
commercially available wound management products use collagen to foster skin regeneration 
[9]. Gelatin results from collagen denaturation and since it retains some of its precursor 
chemotactic signals (such as RGD amino acid sequence, which promotes cell adhesion [10]), 
it has been considered as a cost-effective alternative to collagen for the potential application 
in skin tissue engineering [11, 12]. In this study, the resistance of the prepared scaffolds to 
collagenase was studied to simulate the digestive environments promoted by this enzyme that 
exists in chronic wounds. During wound healing, fibroblasts represent one of the major cell 
types that should successfully proliferate, integrate, and regenerate in the wound area [13]. 
The response of fibroblasts to the prepared samples was studied in-vitro using cytotoxicity 
assays according to the ISO 10993-5 guidelines. The gelatin molecular structure was studied 
using Fourier Transform Infra-Red Spectroscopy (FT-IR) and the mechanical properties of 
the samples were characterised using tensile strength analysis. 
2. Materials and Methods 
2.1. Scaffold Preparation Method 
A previous report on executing in-situ gas foaming method showed that initiating the 
chemical reaction and releasing the gas within the confinement of the mould cause 
undesirable effects on the pore size distribution of the scaffolds [7]. Under such experimental 
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conditions, the released gas cannot be vented off from the mould and this will lead to over-
pressurisation within the solution which subsequently causes macro bubbles to be formed. 
Larger bubbles would consequently form a larger pore size in the final structure of scaffolds. 
In this study, in order to avoid such conditions, the chemical reaction and the subsequent gas 
release were executed outside the mould and the resulting foam was then injected into the 
mould to form a final structure. Type B gelatin powder (Sigma Aldrich, USA) was used to 
prepare 20% w/v gelatin solution in de-ionised water. To initiate foaming, 0.32 g of sodium 
bicarbonate (BDH Chemical, UK) was added directly to the gelatin solution. After 10 
seconds, 360 l of acetic acid (Fisher Scientific, UK) was added to the solution to react with 
effervescent phase. The produced gelatin foam was cast in polystyrene moulds (5.5 cm 
diameter). The moulds were pre-cooled and frozen at -25˚C for 1 hour. The frozen foam 
blocks were then extracted from the moulds and placed in de-ionised water to extract 
unreacted components. To crosslink the scaffolds, the samples were then immersed in 
aqueous solutions of glutaraldehyde (GTA) at concentrations of 0.25, 0.50, 0.75, and 
1.00% v/v GTA for 3 hours (adjusted to a pH of 5). The GTA solutions were prepared from a 
50% v/v aqueous stock solution of GTA (Fisher Scientific, UK). The samples were washed in 
de-ionised water overnight, frozen, and lyophilised at -40˚C under a vacuum pressure of 
0.250 mbar for a day. Non-crosslinked samples were prepared as a control in absence of the 
crosslinking step. 
2.2. Characterisation of the Prepared Scaffolds 
2.2.1. Mechanical Properties 
Tensile strength, Young’s modulus, and tensile strain of the scaffolds were determined 
using a Texture Analyzer (TA.XT-Plus, Stable Micro Systems, UK). After conditioning the 
samples at 20˚C and 95% relative humidity for 2 days, the samples were cut into rectangular 
strips (10 × 5mm), the thickness was measured at 3 points and the average values were 
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recorded. The samples were drawn with a cross head speed of 0.033 mm.sec-1. The linear 
segment of Stress-Strain curve was used to determine the Young’s modulus and the values 
reported in kPa. The tensile strength and strain values are reported in kPa and percentage (%), 
respectively. The tests were performed in triplicate. 
2.2.2. Thermal Analysis 
Differential Scanning Calorimetry (DSC - 822e, Mettler-Toledo, Switzerland) was used 
to perform thermal analysis. The samples were conditioned at 65% relative humidity and 
20˚C for 2 days, they were cut and sealed in 40 l aluminum pans. The samples were heated 
from 15 to 100˚C at a heating rate of 5˚C.min-1 under inert atmosphere of nitrogen gas. The 
peak temperature and the normalised enthalpy of transition for each sample were recorded. 
The peak temperature of thermograph was assigned as the gelatin denaturation 
temperature (Td). The normalised enthalpy of transition was computed as the integrated area 
under the transition peak. The experiments were performed in triplicate. 
2.2.3. Fourier Transform Infra-Red Spectroscopy (FT-IR) 
Fourier Transform Infra-Red spectroscopy (FTIR/ATR-4800s, Shimadzu, Japan) was 
performed by scanning from 4000 to 1000 cm-1. The samples were conditioned in a 0% 
relative humidity desiccator for 2 days prior to analysis. Multiple scans were performed on 
each sample and a representative FT-IR diagram for each sample is chosen for discussion. 
2.2.4. Crosslinking Index 
The degree of crosslinking was assessed according to the Ninhydrin Assay method 
reported by Sun et al., with minor modifications [14]. Briefly, gelatin scaffolds were weighed 
and added to 2 ml aliquot of 50% v/v aqueous ninhydrin reagent solution. The samples were 
heated in 100˚C water for 20 minutes. The samples were then cooled at room temperature and 
5 ml of 50% v/v ethanol-water solution was added. The samples were vortexed for 15 
seconds and the absorption was measured at 570 nm (UV-250IPC, Shimadzu, Japan). 
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Aqueous solutions of glycine with known standard concentrations were used to plot the 
calibration curve. The non-crosslinked samples were used to estimate the number of free 
amine groups available per mass unit of pure gelatin (N non-crosslinked). The crosslinking index 
is reported as a percentage and defined as the number of free amine groups available in the 
crosslinked sample (N crosslinked) normalised to N non-crosslinked (Equation 1). 
                           (Equation 1) 
2.2.5. Microstructure Analysis 
The scaffolds were examined using a Scanning Electron Microscope (SEM, S-3000N, 
Hitachi, Japan) operated at 5kV. Samples were gold-coated using a sputter coater (SC500, 
Mscope, UK). The average pore size of the samples was determined using Quartz PCI image 
processing software package (Quartz Image Corp., Vancouver, Canada). 
2.2.6. In-Vitro Biodegradation Assay 
Assessing the resistance of a wound dressing against enzymatic degradation may be a 
useful tool in estimating the biodegradability of scaffold in-vivo. Biodegradation assays were 
carried out using collagenase according to the method described by Melling et al. with some 
modifications [15]. The scaffolds were cut and their dry weights were recorded. Collagenase, 
from Clostridium Histolyticum (125 CDU/mg, Sigma, USA) was dissolved in PBS to obtain 
concentrations of 2.5 and 5 mg/ml with enzymatic activities of 625 and 317.5 CDU/ml, 
respectively. The enzyme solution (300 l) was added to 100 mMol CaCl2 solution (500 l). 
The final mixture was diluted to 5 ml total volume with PBS. A set of control samples was 
prepared by incubating the samples in de-ionised water for comparison. All samples were 
incubated in an orbital water bath at 40 rpm and 37˚C for a day. The solutions were 
centrifuged for 5 minutes at 1000g at 5˚C (Megafuge 16R, Thermo Scientific, Germany). The 
non-digested samples were collected using filter paper No. 541 and dried at 100˚C. The 
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samples were dried until constant weight (to 2 decimal places). The final constant weight was 
recorded as the residual non-degraded mass. The degradation ratio was computed for each 
sample as the ratio of residual non-degraded mass to the initial mass (Equation 2): 
        (Equation 2) 
2.2.7. Cytotoxicity Analysis 
Prior to cytotoxicity analysis, the scaffold samples were sterilised under UV light for 6 
hours. The ISO 10993-5 guidelines were used to perform indirect cytotoxicity tests [16]. 
Briefly, triplicate scaffold samples (3×3×5 mm) were incubated in 2ml Dulbecco’s Modified 
Eagle’s Medium (DMEM, Gibco, UK) with 10% v/v of Fetal Bovine Serum (FBS, Gibco, 
UK) in polystyrene tubes (BD Bioscience, USA) at 37˚C, 5% CO2, and fully humidified air 
for 3 days. The liquid extracts were used to culture L929 mouse fibroblast cell line (DSMZ, 
Germany) with an initial density of 80×103 cell/cm2 in 24-well plates for 3 days. The cell 
metabolic activity was determined using a MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide) cell proliferation kit (Sigma Aldrich, USA). The results were 
normalised to the negative control (fresh DMEM with 10% FBS medium) and compared with 
the positive control (medium pre-incubated with latex). 
2.2.8. Statistical Analysis 
Non-parametric tests were undertaken using the Kruskal-Wallis Method with SPSS 
Statistics software (Ver. 20, IBM, NY, USA). The analysis showed the presence of any 
significant differences amongst the results at p ≤ 0.05. 
3. Results 
3.1. Mechanical Properties 
Table 1 lists the tensile properties of the scaffolds crosslinked at different 
concentrations of GTA. In comparison with the non-crosslinked samples, only the 0.50% v/v 
GTA concentration significantly increased the scaffolds tensile strength (p≤0.05). The 
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increase of tensile strength for the samples crosslinked at 0.25% v/v GTA was not significant 
in comparison with the non-crosslinked samples (p≤0.05). Similar comparison shows that 
crosslinking at concentrations higher than 0.50% v/v significantly decreased the tensile 
strength of scaffolds (p≤0.05). 
Table 1: Tensile properties of the prepared gelatin scaffolds at various GTA concentrations. The tensile strain of 









0.00  80.76 (±4) 0.87 (±0.1) 114.83 (±9) 
0.25 100.10 (±13) 2.09 (±0.1) 38.57 (±1) 
0.50 239.48 (±70) 2.44 (±0.4) 30.23 (±5) 
0.75 59.22 (±14) 1.80 (±0.1) 30.02 (±0.4) 
1.00 15.46 (±5) 4.07 (±1.3) 17.88 (±5) 
As the result of crosslinking, the Young’s modulus of the scaffolds was increased from 
0.87 kPa in the non-crosslinked samples to higher values in all of the crosslinked scaffolds. 
The scaffolds crosslinked with 1% v/v GTA had the highest Young’s modulus (4.07 kPa), 
which was significantly higher than the non-crosslinked samples (p≤0.05). 
The tensile strain of the scaffolds decreased significantly as a result of crosslinking. 
The non-crosslinked samples showed an elongation value of 114.8%, whilst the scaffolds 
crosslinked with 1.00% v/v GTA showed the lowest elongation at 17.9% which was 
significantly less than non-crosslinked samples (p≤0.05). 
3.2. Thermal Analysis 
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Table 2 lists the thermal characteristics of gelatin scaffolds crosslinked at different 
concentrations of GTA. As a result of crosslinking the denaturation temperature (Td) was 
increased from 48˚C in the non-crosslinked samples to the temperature above 80˚C in all of 
the crosslinked scaffolds. Denaturation temperature is an indirect measurement of the 
crosslinking degree. A higher denaturation temperature value delineates a greater degree of 
crosslinking [17]. As the result of crosslinking, the enthalpy of transition (∆H) shifted to 
smaller negative values. The enthalpy of transition was changed from -25.7 J.g-1 in the non-
crosslinked samples to -12.3 J.g-1 in the scaffolds crosslinked with 1% v/v GTA. 
Table 2: Thermal analysis of porous gelatin scaffolds crosslinked at different concentrations of GTA. Peak 
temperature is assigned as Td in this study. Results are shown as an average ± standard deviation. 
GTA concentration 
(% v/v) 
Denaturation Temperature (Td) 
(˚C) 
Enthalpy of Transition (∆H) 
(J.g-1) 
0.00  48.1 (± 6.9) -25.7 (±16.7) 
0.25  82.0 (±3.5)  -16.4 (±0.4) 
0.50  84.5 (± 1.5) -16.3 (±0.9) 
0.75  86.2 (±1.6) -13.2 (±3.2) 
1.00  83.8 (±1.4) -12.3 (±1.8) 
3.3. Fourier Transform Infra-Red Spectroscopy (FT-IR) 
Figure 1 compares the FT-IR spectra of gelatin scaffolds crosslinked at different GTA 
concentrations. Gelatin amide absorptions are noticeable in all of the non-crosslinked and 
crosslinked spectra. This includes amide I, II, and III at 1633, 1540, and 1238 cm-1, 
respectively. The amide A and B absorptions were evident at 3400 and 3050 cm-1, 
respectively. Carbon and oxygen atoms interactions as part of the gelatin carbonyl groups 
(C=O) cause the Amide I absorption [18]. N-H bending and N=C stretching in amide 
linkages are responsible for both the amide II and amide III absorptions [19]. Amide A and 
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amide B are assigned to the vibrations of hydroxyl groups (O-H) and N-H stretching 
vibrations, respectively [20]. An absorption peak at 3425 cm-1, which corresponds to the -OH 
stretching band [21], is noticeable in the non-crosslinked samples spectrum but it was absent 
from the spectra of crosslinked scaffolds. 
 
Fig. 1 The FT-IR spectra of non-crosslinked and crosslinked samples. The shoulder-like absorption at 3425 cm-1 
(marked by *) was visible in the non-crosslinked samples and was absent in the crosslinked samples. This 
absorption band represents -OH hydroxyl functional groups and its disappearance may be indicative of OH 
functional groups consumption during the crosslinking process 
3.4. Crosslinking Index 
Figure 2 compares the change in the degree of crosslinking index as a function of GTA 
concentration. GTA solution with a concentration of 0.25% v/v crosslinked 92% of the free 
amine groups when compared with non-crosslinked samples. Increasing GTA concentration 
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above this value did not change the crosslinking index significantly (p≥0.05). Therefore 
crosslinking of gelatin scaffolds with GTA appeared to have been optimised at 0.25% v/v 
GTA. 
 
Fig. 2 The crosslink index is reported as the number of free amine groups available in the crosslinked sample 
normalised to the number of free amine groups in non-crosslinked scaffolds. The crosslink index stayed stable 
above 90% value, regardless of GTA concentration 
3.5. Microstructure Analysis 
Figure 3 (A-F) displays the microstructure of the porous gelatin scaffolds. The structure 
of the prepared scaffolds showed an inter-connected porous matrix. The average pore size for 
the non-crosslinked scaffolds was 180m. The scaffolds crosslinked with 0.50 and 
1% v/v GTA showed an average pore size of 233m and 306m, respectively. Due to 
softness and plastic properties of the non-crosslinked scaffolds (as reported in Section 3.1), 
sectioning and preparation of samples for SEM analysis caused distortion of pores for this set 
of samples (Figure 3-A). The microstructure of the crosslinked scaffolds showed 
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interconnectivity which is critical for cell migration and proliferation and facilitating the 







Fig. 3 SEM images at 50x and 100x magnifications showing interconnectivity and the pore structure of gelatin 
scaffolds as a function of GTA concentration (0% to 1% v/v). (A, B) non-crosslinked samples; (C, D) scaffolds 
crosslinked with 0.50% v/v GTA solution; (E, F), scaffolds crosslinked with 1% v/v GTA solution 
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3.6. In-Vitro Biodegradation Assay 
Figure 4 shows the results of the biodegradation analysis performed using two different 
collagenase concentrations (119 and 234 CDU/ml) in comparison with a set of control 
samples that were incubated in de-ionised water only. In the absence of enzyme, crosslinking 
samples at all concentrations of GTA sufficiently stabilised the gelatin scaffolds in 37˚C de-
ionised water for a day. However, upon the addition of enzyme, a noticeable difference 
between the effects of different GTA concentrations on the scaffolds stability was observed. 
At a collagenase concentration of 119 CDU/ml, the degradation rate of the samples 
crosslinked with 0.25% v/v GTA was 39.5% of the initial mass after a day of enzymatic 
hydrolysis. At GTA concentrations greater than 0.25% v/v, less than 10% of the samples 
initial mass was degraded during the same incubation period. At higher concentration of 
collagenase (234 CDU/ml), after a day of incubation with the enzyme, 91% of initial mass of 
scaffolds crosslinked at 0.25% v/v GTA was degraded and the scaffolds crosslinked with 1% 
v/v GTA showed a degradation rate of less than 30% of the initial mass. 
 
Fig. 4 The results of in-vitro biodegradation analysis using collagenase enzyme as a function of GTA 
concentrations. These results are compared with a set of control samples that were incubated in 37˚C de-ionised 
water without enzyme 
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3.7. Cytotoxicity Evaluation 
L929 cells metabolic activities were assessed in an indirect cytotoxicity test according 
to the ISO 10993-5 guidelines. Cytotoxicity results were normalised to the negative control 
and compared with the positive control (Figure 5). At the lowest GTA concentration, there 
was a 10% increase in toxicity level, whilst at the greatest GTA concentration, there was a 
32% increase in the cytotoxicity level. However, the reduction of cell viability as a result of 
crosslinking was not statistically significant (p≥0.05). 
 
Fig. 5 Cell metabolic activity as measured in an indirect cytotoxicity test. Results are normalised to the negative 
control and compared with the positive control. Results are shown as an average ± standard deviation 
4. Discussion 
Due to both the aging population (longer lifespan) and the concurrent increase in 
comorbidities such as diabetes, obesity, and peripheral vascular diseases, the incidence of 
chronic wounds has been growing in developed countries. Treatment of such wounds 
imposes an increasing burden on the healthcare budget of these countries. In the UK alone, 
the allocated annual budget for the chronic wound management is estimated to top £3 billion 
[23]. Manufacturing smarter and more effective wound dressings may be instrumental in 
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improving life quality of the affected population and bringing the costs of wound 
management under control. In the past two decades, a new generation of wound dressings 
have been developed that employs the principles of tissue engineering for treatment and 
management of chronic wounds [8]. Advanced wound dressings are capable of supporting 
cell growth and they may safely be implanted and left in-situ in the skin after successful 
tissue regeneration [24]. To support cell growth and successful integration in natural skin 
tissue, the wound dressings need to provide mechanical support, be porous, and provide 
chemotactic signals to the surrounding cells [22]. Considering the similarity of gelatin to skin 
collagen, the former can provide biological recognition signals to cells and by designing 
structures with desirable mechanical properties, porosity, and in-vivo stability, a promising 
gelatin-based wound dressing for the application in chronic wound treatments may be 
obtained. 
The mechanical strength of human skin differs in various parts of body, and has been 
reported to be between 0.13 to 0.32MPa in the area of forearms and forehead [25]. In this 
research study, depending on the applied GTA concentration, the prepared scaffolds showed 
a maximum tensile strength of 0.24 MPa (Table 1). Although the initial increase of GTA 
concentrations led to an increase in the tensile strength, there is a limit in the ability of using 
GTA crosslinking in increasing the tensile strength. Comparing with non-crosslinked 
samples, the tensile strength of the scaffold reached a maximum at the GTA concentration of 
0.50% v/v. Upon further increase of GTA concentration, the strength of scaffold was 
significantly decreased. Such a decrease in tensile strength at high concentrations of 
crosslinker has been observed by other researchers [26-28]. It is suggested that such a decline 
is a result of increasing brittleness and existing porosity which act as points of crack 
propagation [29]. Price (1986) points to the increase of structural brittleness as the root cause 
for the decrease in the tensile strength. The observed significantly greater Young’s modulus 
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at high concentrations of GTA was similar to reported results by Price (1986). In porous 
structures (such as samples in this study), an increase in the brittleness would lead to faster 
rate of crack growth and structural failure at lower tensile strengths. In comparison with our 
previous report describing a structures prepared with in-situ gas foaming [7], the tensile 
strength results in Table 1 are noticeably greater, whilst similar comparison with previously 
reported results shows that the average pore sizes reported in Section 3.5 are lower [7]. 
Considering the impact of porosity on the tensile strength [29], the relatively higher tensile 
strength observed in this study may be due to smaller pore structure. This may point to the 
impact of releasing gas before mould casting on reducing the pore size average and helping in 
tensile strength increase. 
 
Fig. 6 Proposed reaction mechanism of aldehydic groups with: (A) gelatin amine groups and the formation of 
C=N bonds [30], (B) proposed GTA reaction with the hydroxyl groups of hydroxyproline at acidic pH’s [21]. 
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An increase in mechanical strength of crosslinked structures is a direct result of 
covalent bonds formation between polymeric macromolecules [21]. The effectiveness of 
crosslinking and the extent of covalent bond formation after crosslinking can be measured 
indirectly through thermal analysis. The formation of covalent bonds between the gelatin 
molecules as a result of crosslinking is responsible for the increase in the denaturation 
temperature (Table 2) [17]. Denaturation temperature (Td) is associated with the proteins 
unfolding and aggregation as a result of heating. The intermolecular restriction in the 
mobility of gelatin molecules as a result of crosslinking causes the entropy of transition to 
decrease [31] and thus the denaturation and unfolding of the protein molecules require higher 
amount of energy and therefore a higher temperature to proceed [32]. An increase of 
denaturation temperature confirms crosslinking within the gelatin structure. The FT-IR 
results may provide further additional information with regards to the mechanism of gelatin 
crosslinking with GTA (Figure 1). The main reaction of GTA with gelatin includes 
establishment of covalent bonds between the amine groups of lysine (hydroxylysine). It is 
suggested that the prominent GTA reaction mechanism is the Schiff base reaction [33] and 
includes the establishment of carbon and nitrogen double bonds (C=N) between GTA and 
gelatin molecules (Figure 6-A). At acidic pH’s, this reaction is less probable due to the 
protonation of amine groups [21]. Farris et al. (2010) suggested an alternative reaction 
mechanism for GTA reaction with proteins under acidic pH’s. According to Farris et al. 
(2010) at low pH’s the crosslinking may be carried out through the protonation of the carbon 
in the GTA aldehydic group with the subsequent reaction with -OH groups of hydroxyproline 
and hydroxylysine, resulting in the formation of ether bonds [21]. Figure 6-B illustrates the 
proposed aldehyde reaction with hydroxyproline at acidic pH’s. In Figure 1, in the absence of 
a crosslinker, there is a shoulder-like absorption band at 3425 cm-1 which corresponds to the 
gelatin -OH stretching band. However, for the crosslinked samples, this absorption band 
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almost disappeared which suggests the -OH group may have been involved in the reaction 
with the GTA. Figure 1 may show that GTA reaction with hydroxyl functional groups was 
involve in crosslinking mechanism. 
In order to assist the closure of wounds, an optimal wound dressing should be resistant 
to the surrounding digestive conditions that prevail in the early stages of wound healing. The 
wound healing stages may be divided into four phases that occur in the following 
chronological order: Haemostasis, Inflammation, Proliferation, and Remodeling [34]. The 
inflammation phase is marked by a high activity of matrix metalloprotase enzymes (MMP’s) 
such as collagenase, whilst the next phase (proliferation) is marked by rapid fibroblast growth 
and migration into the injured area. An effective wound dressing needs to withstand the 
inflammation phase of wound healing with resistance to degradation until the beginning of 
the proliferation phase which is expected three days after initial injury [34]. For this to occur, 
a rate of less than 30% mass degradation per day is desirable. The rate of scaffold 
degradation was a function of enzyme concentration, as it is shown in Figure 4. Whilst the 
majority of the crosslinked scaffolds showed degradation rate of less than 30% mass 
degradation per day at the collagenase concentration of 119 CDU/ml, at the highest 
concentration of collagenase (234 CDU/ml), only the scaffolds crosslinked with 1% v/v GTA 
exhibited a degradation rate of less than 30% mass degradation per day. There are qualitative 
and quantitative differences amongst the digestive components of different types of chronic 
wounds; for instance, chronic venous ulcers show higher content and diversity of MMP 
enzymes than pressure ulcers [35]. Whereas the scaffolds crosslinked with low range of GTA 
concentrations can be resistant against moderate digestive wound environments, the 
application of 1% v/v GTA crosslinking is necessary for a highly digestive wound 
environment such as venous ulcers. Despite higher resistance against degradation, 
cytotoxicity evaluations showed that scaffolds crosslinked with 1% v/v GTA were three times 
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more toxic than the samples crosslinked with 0.25% v/v GTA. This reaffirms the need to find 
a less cytotoxic crosslinker than GTA in order to have both acceptable in-vivo stability and a 
satisfying biocompatibility. It should be pointed out that this research study was mainly 
aimed at optimising the in-situ gas foaming method and GTA was used as a model 
crosslinker for this purpose. Further studies on applications of alternative crosslinkers will be 
the subject of future studies. 
5. Conclusion 
In this study, a porous gelatin scaffold with an inter-connected porous system was 
prepared using in-situ gas foaming optimisation. The recommended pore size range for skin 
tissue engineering scaffolds is reported to be 20-125m [2]. In this study, the prepared 
scaffolds showed an average pore size more similar to this optimum range than previous 
report on the outcome of in-situ gas foaming application [7]. The prepared scaffolds showed 
a relatively similar tensile strength to human skin that protects the areas of forehead and 
forearm. A limit was detected in the ability of GTA in increasing the tensile strength of 
scaffolds. Upon increase of GTA concentration above 0.50% v/v GTA, the tensile strength of 
the scaffolds was significantly reduced. This was attributed to brittleness of the structures as a 
result of over-crosslinking and porous feature of the scaffolds. As expected, an increase of 
GTA concentration had a cytotoxic effect on cultured cells. However, it should be pointed out 
that the main objective of this study was optimising the in-situ gas foaming procedure and 
GTA was used as a model crosslinker with an effective, reliable, and rapid stabilising impact. 
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